Exploring the association between pulse wave velocity and CKD progression: a longitudinal study in Mashhad, Iran

1. Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic Kidney Disease. Lancet ;389(10075), 1238–1252 (2017).

2. Thompson, S. et al. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 26(10), 2504–2511 (2015).

   Google Scholar 

3. Jankowski, J., Floege, J., Fliser, D., Boehm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11), 1157–1172 (2021).

   Google Scholar 

4. Sedaghat, S. et al. Arterial stiffness and decline in kidney function. Clin. J. Am. Soc. Nephrol. 10(12), 2190–2197 (2015).

   Google Scholar 

5. Voicehovska, J. G. et al. Association of arterial stiffness with chronic kidney disease progression and mortality. Heart Lung Circ. 30(11), 1694–1701 (2021).

   Google Scholar 

6. Tomiyama, H. et al. Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis 212(1), 345–350 (2010).

   Google Scholar 

7. Madero, M. et al. Association of arterial rigidity with incident kidney disease and kidney function decline: the health ABC study. Clin. J. Am. Soc. Nephrol. 8(3) (2013).

8. Ford, M. L., Tomlinson, L. A., Chapman, T. P., Rajkumar, C. & Holt, S. G. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 55(5), 1110–1115 (2010).

   Google Scholar 

9. Levey, A. S. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med. 130(6), 461–470 (1999).

   Google Scholar 

10. Mitchell, G. F. et al. Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation 121(4), 505–511 (2010).

    Google Scholar 

11. Coresh, J. et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am. J. Kidney Dis. 39(5), 920–929 (2002).

    Google Scholar 

12. Initiative, K. D. O. Q. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. (2002).

13. Briet, M. et al. Arterial remodeling associates with CKD progression. J. Am. Soc. Nephrol. 22(5), 967–974 (2011).

    Google Scholar 

14. Upadhyay, A. et al. Arterial stiffness in Mild-to-Moderate CKD. J. Am. Soc. Nephrol. 20(9), 2044–2053 (2009).

    Google Scholar 

15. Lilitkarntakul, P. et al. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis 216(1), 217–225 (2011).

    Google Scholar 

16. Shinohara, K. et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 65(3), 936–943 (2004).

    Google Scholar 

17. Wang, M. C., Tsai, W. C., Chen, J. Y. & Huang, J. J. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am. J. Kidney Dis. 45(3), 494–501 (2005).

    Google Scholar 

18. Hermans, M. M. et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn study. J. Am. Soc. Nephrol. 18(6), 1942–1952 (2007).

    Google Scholar 

19. Laurent, S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27(21), 2588–2605 (2006).

    Google Scholar 

20. Ikonomidis, I. et al. Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension. Am. J. Hypertens. 21(7), 806–813 (2008).

    Google Scholar 

21. Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118(17), 1748–1757 (2008).

    Google Scholar 

22. Chung, A. W. et al. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 120(9), 792–801 (2009).

    Google Scholar 

23. Safar, M. E., London, G. M. & Plante, G. E. Arterial stiffness and kidney function. Hypertension 43(2), 163–168 (2004).

    Google Scholar 

24. Townsend, R. R. et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am. J. Hypertens. 23(3), 282–289 (2010).

    Google Scholar 

25. Temmar, M. et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J. Hypertens. 28(1), 163–169 (2010).

    Google Scholar 

26. Haider, A. W., Larson, M. G., Franklin, S. S. & Levy, D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham heart study. Ann. Intern. Med. 138(1), 10–16 (2003).

    Google Scholar 

27. McIntyre, N. J., Fluck, R. J., McIntyre, C. W. & Taal, M. W. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin. J. Am. Soc. Nephrol. 6(10), 2356–2363 (2011).

    Google Scholar 

28. Fesler, P., Safar, M. E., du Cailar, G., Ribstein, J. & Mimran, A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J. Hypertens. 25(9), 1915–1920 (2007).

    Google Scholar 

Download references

Author notes

1. These authors contributed equally: Susan Darroudi and Naiemeh Varasteh.

Authors and Affiliations

1. Vascular and Endovascular Surgery Research Center, Mashhad University of medical sciences, Mashhad, 99199-91766, Iran

   Susan Darroudi & Naiemeh Varasteh

2. Department of Biochemistry and Biophysics, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran

   Hayder Taha Yaseen

3. Kidney transplantation complications research center, Mashhad University of Medical Sciences, Mashhad, Iran

   Reza Salehi Manzari

4. Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

   Vahid Mahdavizade, Abbas Mohtashamian, Amir Mohammad Kamali & Amirhosein Zardast

5. Department of Nutritional sciences, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

   Abbas Mohtashamian

6. Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran

   Faezeh Nematolahi

7. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran

   Faezeh Nematolahi

8. Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran

   Habibollah Esmaily

9. Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

   Habibollah Esmaily

10. Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran

    Eisa Nazar

11. Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran

    Eisa Nazar

12. Non communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran

    Narges Fereydouni

13. Department of Tissue Engineering, Faculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran

    Narges Fereydouni

14. Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex, BN1 9PH, UK

    Gordon A. Ferns

15. Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 99199-91766, Iran

    Majid Ghayour-Mobarhan & Mohsen Moohebati

16. International UNESCO center for Health Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, 99199-91766, Iran

    Majid Ghayour-Mobarhan

17. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Maryam Saberi-Karimian

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by SD, EN, NV, AZ, RSM, VM, AMK, FN, HE, GAF, MM, MSK and MGM. The first draft of the manuscript was written SD, EN, NV, AZ, RSM, AM, HTY and VM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Mohsen Moohebati or Maryam Saberi-Karimian.

Competing interests

The authors declare no competing interests.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Mashhad University of Medical Sciences.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions